根据 位华尔街分析师的预测,Motus GI Holdings Inc 的收入预期范围从 $ 到 $
Motus GI Holdings Inc 的盈利质量评分是多少?
Motus GI Holdings Inc 的盈利质量评分为 B+/50.806385。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Motus GI Holdings Inc 何时发布财报?
Motus GI Holdings Inc 的下一份财报预计在 2025-10-21 发布
Motus GI Holdings Inc 的预期收益是多少?
根据华尔街分析师的预测,Motus GI Holdings Inc 的预期收益为 $1.31M
Motus GI Holdings Inc 是否超出收益预期?
Motus GI Holdings Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$0.0001
开盘价
$0.0001
当日区间
$0.0001 - $0.0001
52周范围
$0.0001 - $0.1
交易量
1
平均成交量
930
股息收益率
--
每股收益(TTM)
-12.69
市值
$639
什么是 MOTS?
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. The company is headquartered in Fort Lauderdale, Florida and currently employs 15 full-time employees. The company went IPO on 2018-02-14. The company has developed the Pure-Vu System, a medical device that facilitates the cleansing of a gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (GI) endoscopy procedures. The Pure-Vu System integrates with colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Its system consists of a workstation controller and a single-use, disposable Flex-Channel that attaches to most gastroscopes and colonoscopes (endoscopes). Together with the endoscopes, the Pure-Vu System performs intra-procedural cleaning. The Flex-Channel has an umbilical section that connects the disposable to the workstation. The workstation delivers an irrigation medium of air and water that creates a pulsed vortex inside the GI tract to break up debris while simultaneously evacuating the content into waste receptacles.